欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
GW9662_22978-25-2_产品详情
22978-25-2
  • names:

    GW9662

  • CAS号:

    22978-25-2

    MDL Number:
  • MF(分子式): C13H9ClN2O3 MW(分子量): 276.68
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
GW9662
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002656-10mg 10mg 99.74% ¥ 1890.00 ¥ 1890.00 2-3天
- +
¥ 0.00
YZM002656-5mg 5mg 99.74% ¥ 774.80 ¥ 774.80 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 22978-25-2
Inchi
InchiKey
分子式 Formula C13H9ClN2O3
分子量 Molecular Weight 276.68
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(361.43 mM)H2O< 0.1 mg/mL(insoluble)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
GW9662(CAS:22978-25-2)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 GW9662为有效,选择性的PPARγ拮抗剂,IC50值为3.3 nM,比PPARα和PPARδ的选择性高10倍和1000倍
IntroductionGW9662 is a potent and selectivePPARγantagonist with anIC50of 3.3 nM, showing 10 and 1000old selectivity over PPARα and PPARδ, respectively.
Application1
Application2
Application3
GW9662为有效,选择性的PPARγ拮抗剂,IC50值为3.3 nM,比PPARα和PPARδ的选择性高10倍和1000倍。GW9662 is a potent and selectivePPARγantagonist with anIC50of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Leesnitzer LM, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry. 2002 May 28;41(21):6640-50.
【2】.Seargent JM, et al. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation. Br J Pharmacol. 2004 Dec;143(8):933-7.
【3】.Sato K, et al. PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.Haematologica. 2016 Jan;101(1):57-67.
【4】.Collino M, et al. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int. 2005 Aug;68(2):529-36.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents